APELLIS PHARMACTDL (Germany) Price on July 30, 2024
| 1JK Stock | EUR 31.24 0.86 2.68% |
If you're considering investing in APELLIS Stock, it is important to understand the factors that can impact its price. As of today, the current price of APELLIS PHARMACTDL stands at 31.24, as last reported on the 23rd of December, with the highest price reaching 31.24 and the lowest price hitting 31.24 during the day. APELLIS PHARMACTDL appears to be not too volatile, given 3 months investment horizon. APELLIS PHARMACTDL 0001 secures Sharpe Ratio (or Efficiency) of 0.051, which signifies that the company had a 0.051% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for APELLIS PHARMACTDL 0001, which you can use to evaluate the volatility of the firm. Please makes use of APELLIS PHARMACTDL's Downside Deviation of 3.56, mean deviation of 3.02, and Risk Adjusted Performance of 0.0158 to double-check if our risk estimates are consistent with your expectations.
APELLIS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
APELLIS |
Sharpe Ratio = 0.051
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 1JK | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.05 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average APELLIS PHARMACTDL is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of APELLIS PHARMACTDL by adding it to a well-diversified portfolio.
APELLIS PHARMACTDL Valuation on July 30, 2024
It is possible to determine the worth of APELLIS PHARMACTDL on a given historical date. On July 30, 2024 APELLIS was worth 35.61 at the beginning of the trading date compared to the closed value of 35.61. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of APELLIS PHARMACTDL stock. Still, in general, we apply an absolute valuation method to find APELLIS PHARMACTDL's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of APELLIS PHARMACTDL where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against APELLIS PHARMACTDL's related companies.
| Open | High | Low | Close | Volume | |
| 36.02 | 36.02 | 36.02 | 36.02 | 39.00 | |
07/30/2024 | 35.61 | 35.61 | 35.61 | 35.61 | 39.00 |
| 35.57 | 35.57 | 35.57 | 35.57 | 39.00 |
| Backtest APELLIS PHARMACTDL | | | APELLIS PHARMACTDL History | | | APELLIS PHARMACTDL Valuation | Previous | Next |
APELLIS PHARMACTDL Trading Date Momentum on July 30, 2024
| On July 31 2024 APELLIS PHARMACTDL 0001 was traded for 35.57 at the closing time. The highest daily price throughout the period was 35.57 and the lowest price was 35.57 . The daily volume was 39.0. The net trading volume on 07/31/2024 added to the next day price reduction. The daily price change to closing price of the next trading day was 0.11% . The overall trading delta to current closing price is 5.14% . |
APELLIS PHARMACTDL 0001 Fundamentals Correlations and Trends
By evaluating APELLIS PHARMACTDL's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among APELLIS PHARMACTDL's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. APELLIS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About APELLIS PHARMACTDL Stock history
APELLIS PHARMACTDL investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for APELLIS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in APELLIS PHARMACTDL 0001 will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing APELLIS PHARMACTDL stock prices may prove useful in developing a viable investing in APELLIS PHARMACTDL
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts. APELLIS PHARMACT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 445 people.
APELLIS PHARMACTDL Stock Technical Analysis
APELLIS PHARMACTDL technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
APELLIS PHARMACTDL Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
APELLIS PHARMACTDL 0001 cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
APELLIS PHARMACTDL December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how APELLIS PHARMACTDL stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading APELLIS PHARMACTDL shares will generate the highest return on investment. By undertsting and applying APELLIS PHARMACTDL stock market strength indicators, traders can identify APELLIS PHARMACTDL 0001 entry and exit signals to maximize returns
APELLIS PHARMACTDL Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for APELLIS PHARMACTDL's price direction in advance. Along with the technical and fundamental analysis of APELLIS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of APELLIS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0158 | |||
| Jensen Alpha | 0.029 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0026 | |||
| Treynor Ratio | 0.2753 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for APELLIS Stock analysis
When running APELLIS PHARMACTDL's price analysis, check to measure APELLIS PHARMACTDL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy APELLIS PHARMACTDL is operating at the current time. Most of APELLIS PHARMACTDL's value examination focuses on studying past and present price action to predict the probability of APELLIS PHARMACTDL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move APELLIS PHARMACTDL's price. Additionally, you may evaluate how the addition of APELLIS PHARMACTDL to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |